# TRIM50

## Overview
TRIM50 is a gene that encodes the protein tripartite motif containing 50, which is a member of the tripartite motif (TRIM) family. This protein is characterized by its E3 ubiquitin ligase activity, facilitated by a tripartite motif comprising a RING domain, B-box domains, and a coiled-coil region. These structural features enable TRIM50 to mediate protein-protein interactions and ubiquitination processes, playing a crucial role in protein homeostasis and cellular regulation (Micale2008Williams–Beuren; Qiu2019TRIM50). TRIM50 is involved in the regulation of autophagy and the formation of aggresomes, which are cytoplasmic structures that sequester and degrade misfolded proteins, thus contributing to protein quality control (Micale2008Williams–Beuren). The protein's interactions with other cellular components, such as HDAC6 and Beclin 1, underscore its involvement in critical cellular pathways, including autophagy and cancer suppression (Qiu2019TRIM50; Fusco2018TRIM50). Alterations in TRIM50 expression have been linked to various diseases, including cancer, highlighting its potential as a therapeutic target (Hu2022Comprehensive; Li2021TRIM50).

## Structure
TRIM50 is a protein encoded by the TRIM50 gene, belonging to the tripartite motif (TRIM) family. The protein is characterized by a tripartite motif that includes a RING domain, one or two B-box domains, and a coiled-coil (CC) region, which are essential for its function as an E3 ubiquitin ligase (Micale2008Williams–Beuren; Qiu2019TRIM50). The RING domain is crucial for mediating interactions with E2 ubiquitin-conjugating enzymes, facilitating the ubiquitination process (Micale2008Williams–Beuren). The B-box domain is involved in protein-protein interactions, such as binding with the SH3 domain of Src, a proto-oncogene (Qiu2019TRIM50). 

TRIM50 can form higher-order structures, including homodimers and trimers, contributing to its stability and function (Micale2008Williams–Beuren). The protein localizes to cytoplasmic aggregates known as aggresomes, which are involved in the sequestration and degradation of misfolded proteins (Micale2008Williams–Beuren). Post-translational modifications of TRIM50 include ubiquitination and acetylation, with lysine residue K372 being a critical site for these modifications (Fusco2014HDAC6). These modifications regulate TRIM50's stability and function, influencing its role in cellular processes (Fusco2014HDAC6).

## Function
TRIM50 is an E3 ubiquitin ligase involved in the ubiquitination process, a post-translational modification that tags proteins for degradation by the proteasome. This function is crucial for maintaining protein homeostasis and cellular regulation. TRIM50 interacts with E2 ubiquitin-conjugating enzymes, particularly UbcH8 (UBE2L6), to facilitate ubiquitination. The RING domain of TRIM50 is essential for its interaction with E2 enzymes, and the protein itself can undergo autoubiquitination (Micale2008Williams–Beuren).

TRIM50 also plays a significant role in regulating autophagy, particularly during the initiation phase. It interacts with Beclin 1, a key regulator of autophagy, promoting its K63-linked ubiquitination, which is crucial for autophagy induction. This interaction enhances Beclin 1's association with ULK1, facilitating the formation of the Vps34/Beclin 1/ULK1 complex necessary for autophagosome formation. The activity of TRIM50 is modulated by acetylation and deacetylation processes, involving enzymes such as p300 and HDAC6, which affect its E3 ligase activity (Fusco2018TRIM50).

In terms of subcellular localization, TRIM50 is found in discrete cytoplasmic structures and shows partial colocalization with peroxisomes. It forms cytoplasmic aggregates known as aggresomes, which are sites for the sequestration and degradation of misfolded proteins, suggesting a role in protein quality control (Micale2008Williams–Beuren).

## Clinical Significance
TRIM50 has been implicated in various diseases and conditions due to its role in protein degradation and regulation of cellular processes. In ovarian cancer, TRIM50 acts as a suppressor by inhibiting the Src protein, which is often upregulated in advanced stages of the disease. Lower levels of TRIM50 are associated with more advanced FIGO stages, higher pathology grades, and lymph node metastasis, suggesting its potential as a therapeutic target in ovarian cancer (Qiu2019TRIM50; Zhao2021The).

In pancreatic cancer, TRIM50 expression is frequently downregulated, correlating with larger tumor size, lymphatic metastasis, and advanced TNM stage. Its overexpression inhibits cell proliferation, induces apoptosis, and suppresses tumor growth, indicating its role as a tumor suppressor. TRIM50 also influences the epithelial-mesenchymal transition (EMT), a process critical for cancer metastasis, by modulating the expression of EMT markers (Li2021TRIM50).

TRIM50 is also involved in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), where its expression is linked to immune modulation and overall survival. Alterations in TRIM50 expression are associated with immune cell infiltration and may influence the progression and prognosis of HBV-related HCC (Hu2022Comprehensive).

## Interactions
TRIM50, a member of the tripartite motif family, is involved in several protein interactions that play crucial roles in cellular processes. It interacts with HDAC6 and p62, which are essential for the aggregation and clearance of polyubiquitinated proteins into the aggresome. This interaction is particularly significant in response to proteasome inhibition, where TRIM50 promotes the recruitment and accumulation of polyubiquitinated proteins to aggresomes (Fusco2012The). The interaction with HDAC6 is dependent on the ubiquitin-binding BUZ finger domain of HDAC6, facilitating the transport of proteins to the aggresome (Fusco2012The). TRIM50 also interacts with p62, a protein involved in the autophagy-lysosome pathway, through its coiled-coil domains (Fusco2012The).

TRIM50 is also involved in autophagy regulation through its interaction with Beclin 1. It promotes the K63-linked ubiquitination of Beclin 1, enhancing its association with ULK1 and facilitating autophagic activity (Fusco2018TRIM50). This interaction underscores TRIM50's role in modulating autophagy initiation, particularly under starvation conditions (Fusco2018TRIM50).

In cancer biology, TRIM50 acts as a suppressor of Src, a protein from the Src family kinases, by directly interacting with it. This interaction involves the B-box domain of TRIM50 and the SH3 domain of Src, suggesting a potential role in inhibiting ovarian cancer progression (Qiu2019TRIM50).


## References


[1. (Qiu2019TRIM50) Yumin Qiu, Peishu Liu, Xiaomin Ma, Xiaoxiao Ma, Lihui Zhu, Yueke Lin, Yajing You, Wenhao Yu, Dapeng Ma, Caiyu Sun, Zhenzhi Qin, Yunxue Zhao, Juanjuan Shi, and Lihui Han. Trim50 acts as a novel src suppressor and inhibits ovarian cancer progression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1866(9):1412–1420, September 2019. URL: http://dx.doi.org/10.1016/j.bbamcr.2019.06.002, doi:10.1016/j.bbamcr.2019.06.002. This article has 18 citations.](https://doi.org/10.1016/j.bbamcr.2019.06.002)

[2. (Micale2008Williams–Beuren) Lucia Micale, Carmela Fusco, Bartolomeo Augello, Luisa M R Napolitano, Emmanouil T Dermitzakis, Germana Meroni, Giuseppe Merla, and Alexandre Reymond. Williams–beuren syndrome trim50 encodes an e3 ubiquitin ligase. European Journal of Human Genetics, 16(9):1038–1049, April 2008. URL: http://dx.doi.org/10.1038/ejhg.2008.68, doi:10.1038/ejhg.2008.68. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2008.68)

[3. (Hu2022Comprehensive) Wei Hu, Dongsheng Liu, Renjie Li, Hong Qian, Wei Qiu, Qingwang Ye, and Fanyun Kong. Comprehensive analysis of trim family genes in hepatitis virus b-related hepatoma carcinoma. Frontiers in Genetics, July 2022. URL: http://dx.doi.org/10.3389/fgene.2022.913743, doi:10.3389/fgene.2022.913743. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.913743)

[4. (Fusco2018TRIM50) Carmela Fusco, Barbara Mandriani, Martina Di Rienzo, Lucia Micale, Natascia Malerba, Dario Cocciadiferro, Eva Sjøttem, Bartolomeo Augello, Gabriella Maria Squeo, Maria Teresa Pellico, Ashish Jain, Terje Johansen, Gian Maria Fimia, and Giuseppe Merla. Trim50 regulates beclin 1 proautophagic activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1865(6):908–919, June 2018. URL: http://dx.doi.org/10.1016/j.bbamcr.2018.03.011, doi:10.1016/j.bbamcr.2018.03.011. This article has 39 citations.](https://doi.org/10.1016/j.bbamcr.2018.03.011)

[5. (Fusco2012The) Carmela Fusco, Lucia Micale, Mikhail Egorov, Maria Monti, Ester Valentina D’Addetta, Bartolomeo Augello, Flora Cozzolino, Alessia Calcagnì, Andrea Fontana, Roman S. Polishchuk, Gerard Didelot, Alexandre Reymond, Piero Pucci, and Giuseppe Merla. The e3-ubiquitin ligase trim50 interacts with hdac6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome. PLoS ONE, 7(7):e40440, July 2012. URL: http://dx.doi.org/10.1371/journal.pone.0040440, doi:10.1371/journal.pone.0040440. This article has 75 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0040440)

[6. (Fusco2014HDAC6) Carmela Fusco, Lucia Micale, Bartolomeo Augello, Barbara Mandriani, Maria Teresa Pellico, Pasquelena De Nittis, Alessia Calcagnì, Maria Monti, Flora Cozzolino, Piero Pucci, and Giuseppe Merla. Hdac6 mediates the acetylation of trim50. Cellular Signalling, 26(2):363–369, February 2014. URL: http://dx.doi.org/10.1016/j.cellsig.2013.11.036, doi:10.1016/j.cellsig.2013.11.036. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2013.11.036)

[7. (Li2021TRIM50) Rongkun Li, Lili Zhu, Yangxizi Peng, Xiaoxin Zhang, Chunhua Dai, and Dejun Liu. Trim50 suppresses pancreatic cancer progression and reverses the epithelial-mesenchymal transition via facilitating the ubiquitous degradation of snail1. Frontiers in Oncology, September 2021. URL: http://dx.doi.org/10.3389/fonc.2021.695740, doi:10.3389/fonc.2021.695740. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.695740)

[8. (Zhao2021The) Guo Zhao, Chuan Liu, Xin Wen, Gan Luan, Longxiang Xie, and Xiangqian Guo. The translational values of trim family in pan-cancers: from functions and mechanisms to clinics. Pharmacology &amp; Therapeutics, 227:107881, November 2021. URL: http://dx.doi.org/10.1016/j.pharmthera.2021.107881, doi:10.1016/j.pharmthera.2021.107881. This article has 31 citations.](https://doi.org/10.1016/j.pharmthera.2021.107881)